“…More importantly, the results suggest that activation of MAPK by VEGFR-2 is not associated with endothelial cell proliferation. Similar results using different endothelial systems have shown that activation of VEGFR-1 is not associated with endothelial cell proliferation (De Vries et al, 1992;Keyt et al, 1996;Fong et al, 1999;Rahimi et al, 2000;Gille et al, 2001). VEGFR-1 activation even in some nonendothelial cells, such as hepatic stellate cells, is reported to attenuate contraction of these cells without effecting DNA synthesis (Mashiba et al, 1999).…”
Section: Discussionsupporting
confidence: 54%
“…Although VEGFR-1 and VEGFR-2 are structurally highly similar, their angiogenic signal transduction appears to differ drastically from each other. Activation of VEGFR-2 positively regulates angiogenesis (Breier 2000;Yancopoulos et al, 2000;Gille et al, 2001) and it is highly autophosphorylated in response to ligand stimulation (Waltenberger et al, 1994;Shalaby et al, 1995;Rahimi et al, 2000). VEGFR-1 is poorly autophosphorylated in response to ligand stimulation in endothelial cells and appears to regulate angiogenesis negatively (Waltenberger et al, 1994;Fong et al, 1999;Rahimi et al, 2000;Kearney et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Selective activation of VEGFR-1 is not associated with endothelial cell migration, intracellular calcium release and angiogenesis in vitro Activation of VEGFR-1 is not associated with endothelial cell proliferation (De Vries et al, 1992;Keyt et al, 1996;Fong et al, 1999;Rahimi et al, 2000;Gille et al, 2001). To test whether VEGFR-1 activation modulates other cellular functions, we subjected cells expressing CTR to cell migration, intracellular calcium release and in vitro angiogenesis.…”
Section: Vegfr-1 Is Devoid Of Ligand-dependent Autophosphorylation Inmentioning
VEGFR-1 is devoid of ligand-dependent tyrosine autophosphorylation and its activation is not associated with proliferation of endothelial cells. The molecular mechanism responsible for this characteristic of VEGFR-1 is not known. In this study, we show that VEGFR-1 is devoid of ligand-dependent downregulation and failed to stimulate intracellular calcium release, cell migration and angiogenesis in vitro. To understand the molecular mechanisms responsible for the poor tyrosine autophosphorylation of VEGFR-1, we have either deleted the carboxyl terminus of VEGFR-1 or exchanged it with the carboxyl terminus of VEGFR-2. The deletion of carboxyl terminus of VEGFR-1 did not reverse its defective ligand-dependent autophosphorylation. The carboxyl terminus-swapped VEGFR-1, however, displayed ligand-dependent autophosphorylation, downregulation and also conveyed strong mitogenic responses. Thus, the carboxyl tail of VEGFR-1 restrains the ligand-dependent kinase activation and downregulation of VEGFR-1 and its ability to convey the angiogenic responses in endothelial cells.
“…More importantly, the results suggest that activation of MAPK by VEGFR-2 is not associated with endothelial cell proliferation. Similar results using different endothelial systems have shown that activation of VEGFR-1 is not associated with endothelial cell proliferation (De Vries et al, 1992;Keyt et al, 1996;Fong et al, 1999;Rahimi et al, 2000;Gille et al, 2001). VEGFR-1 activation even in some nonendothelial cells, such as hepatic stellate cells, is reported to attenuate contraction of these cells without effecting DNA synthesis (Mashiba et al, 1999).…”
Section: Discussionsupporting
confidence: 54%
“…Although VEGFR-1 and VEGFR-2 are structurally highly similar, their angiogenic signal transduction appears to differ drastically from each other. Activation of VEGFR-2 positively regulates angiogenesis (Breier 2000;Yancopoulos et al, 2000;Gille et al, 2001) and it is highly autophosphorylated in response to ligand stimulation (Waltenberger et al, 1994;Shalaby et al, 1995;Rahimi et al, 2000). VEGFR-1 is poorly autophosphorylated in response to ligand stimulation in endothelial cells and appears to regulate angiogenesis negatively (Waltenberger et al, 1994;Fong et al, 1999;Rahimi et al, 2000;Kearney et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Selective activation of VEGFR-1 is not associated with endothelial cell migration, intracellular calcium release and angiogenesis in vitro Activation of VEGFR-1 is not associated with endothelial cell proliferation (De Vries et al, 1992;Keyt et al, 1996;Fong et al, 1999;Rahimi et al, 2000;Gille et al, 2001). To test whether VEGFR-1 activation modulates other cellular functions, we subjected cells expressing CTR to cell migration, intracellular calcium release and in vitro angiogenesis.…”
Section: Vegfr-1 Is Devoid Of Ligand-dependent Autophosphorylation Inmentioning
VEGFR-1 is devoid of ligand-dependent tyrosine autophosphorylation and its activation is not associated with proliferation of endothelial cells. The molecular mechanism responsible for this characteristic of VEGFR-1 is not known. In this study, we show that VEGFR-1 is devoid of ligand-dependent downregulation and failed to stimulate intracellular calcium release, cell migration and angiogenesis in vitro. To understand the molecular mechanisms responsible for the poor tyrosine autophosphorylation of VEGFR-1, we have either deleted the carboxyl terminus of VEGFR-1 or exchanged it with the carboxyl terminus of VEGFR-2. The deletion of carboxyl terminus of VEGFR-1 did not reverse its defective ligand-dependent autophosphorylation. The carboxyl terminus-swapped VEGFR-1, however, displayed ligand-dependent autophosphorylation, downregulation and also conveyed strong mitogenic responses. Thus, the carboxyl tail of VEGFR-1 restrains the ligand-dependent kinase activation and downregulation of VEGFR-1 and its ability to convey the angiogenic responses in endothelial cells.
“…The different phenotypes of these VEGFR Ϫ homozygous mice suggest that VEGFR-2 is the major positive signal transducer, whereas VEGFR-1 has a negative regulatory role in angiogenesis early in embryogenesis. A VEGFR-2-selective VEGF mutant or VEGF-E (a VEGFR-2-specific ligand) is able to induce vascular permeability to an extent indistinguishable from that of wildtype VEGF 165 , whereas a VEGFR-1-selective VEGF mutant or PlGF (a VEGFR-1-specific ligand) has little or no direct permeability-enhancing activity (10,11,14,19). Therefore, not only physiological angiogenesis but also the enhancement of vascular permeability have been considered to be mediated through VEGFR-2 (but not VEGFR-1) activation.…”
Vascular endothelial growth factor (VEGF)/vascular permeability factor induces both angiogenesis and vascular permeability mainly through VEGF receptor (VEGFR)-2 activation. VEGF binds VEGFR-1 as well, but the importance of VEGFR-1 signaling in vascular permeability has been largely neglected. Here, we report the purification and characterization of a novel VEGF-like protein fromTrimeresurus flavoviridisHabu snake venom. The Habu snake has a venom-specific VEGF-like molecule,T. flavoviridissnake venom VEGF (TfsvVEGF), in addition to VEGF-A.TfsvVEGF has almost 10-fold less mitotic activity than VEGF165, a predominant isoform of human VEGF-A, but a similar effect on vascular permeability.TfsvVEGF bound VEGFR-1 and induced its autophosphorylation to almost the same extent as VEGF165, but bound VEGFR-2 weakly and induced its autophosphorylation almost 10-fold less effectively than VEGF165. This unique binding affinity for VEGFR-1 and VEGFR-2 leads to the vascular permeability-dominant activity ofTfsvVEGF. These results suggest that Habu snakes have acquired a highly purposive molecule for a toxin, which enhances the toxicity in envenomation without inducing effective angiogenesis and the following regeneration of damaged tissues, taking advantage of the difference in signaling properties involving VEGFR-1 and VEGFR-2 between vascular permeability and angiogenesis.TfsvVEGF is thus a potent inducing factor selective for vascular permeability through preferential signaling via VEGFR-1. These data strongly indicate the importance of VEGFR-1 signaling in vascular permeability.
“…VEGF exerts its effects on endothelial cells by means of two tyrosine kinase receptors, the fms-like tyrosine kinase-1 (Flt-1; VEGFR-1) and fetal liver kinase-1 (Flk-1͞KDR; VEGFR-2) (7). VEGFR-2 is the dominant signaling receptor for many of VEGF's biological activities, including vascular permeability (8,9).…”
Vascular permeability plays a key role in a wide array of lifethreatening and sight-threatening diseases. Vascular endothelial growth factor can increase vascular permeability. Using a model system for nonproliferative diabetic retinopathy, we found that pigment epithelium-derived factor (PEDF) effectively abated vascular endothelial growth factor-induced vascular permeability. A 44-amino acid region of PEDF was sufficient to confer the antivasopermeability activity. Additionally, we identified four amino acids (glutamate-101, isoleucine-103, leucine-112, and serine-115) critical for this activity. PEDF, or a derivative, could potentially abate or restore vision loss from diabetic macular edema. Furthermore, PEDF may represent a superior therapeutic approach to sepsis-associated hypotension, nephrotic syndrome, and other sight-threatening and life-threatening diseases resulting from excessive vascular permeability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.